Table 1.

The updated cases of 2019‐nCoV pneumonia

Date	Cumulative cases	Regular cases	New cases	Severe cases	Cumulative deaths	Cumulative cured	Fatality rate	Cure rate
1.20	291	139	77	44	6	25	2.062%	8.591%
1.21	440	155	149	102	9	25	2.045%	5.682%
1.22	571	303	131	95	17	25	2.977%	4.378%
1.23	830	335	259	177	25	34	3.012%	4.096%
1.24	1287	527	444	237	41	38	3.186%	2.953%
1.25	1975	858	688	324	56	49	2.835%	2.481%
1.26	2744	1383	769	461	80	51	2.915%	1.859%
1.27	4515	1602	1771	976	106	60	2.348%	1.329%
1.28	5974	3041	1459	1239	132	103	2.210%	1.724%
1.29	7711	4310	1737	1370	170	124	2.205%	1.608%
1.30	9692	5799	1982	1527	213	171	2.198%	1.764%
1.31	11 791	7392	2102	1795	259	243	2.197%	2.061%
2.01	14 380	9048	2590	2110	304	328	2.114%	2.281%
2.02	17 205	11 244	2829	2296	361	475	2.098%	2.761%
2.03	20 438	13 358	3235	2788	425	632	2.079%	3.092%
2.04	24 324	15 836	3887	3219	490	892	2.014%	3.667%
2.05	28 018	18 749	3694	3859	563	1153	2.009%	4.115%
2.06	31 161	21 021	3143	4821	636	1540	2.041%	4.942%
2.07	34 546	22 274	3399	6101	722	2050	2.090%	5.934%
2.08	37 198	24 894	2656	6188	811	2649	2.180%	7.121%
2.09	40 171	26 436	3062	6484	908	3281	2.260%	8.168%
2.10	42 638	27 815	2478	7333	1016	3996	2.383%	9.372%

Note: $\text{Fatality}\mathrm{}\mathrm{r}\mathrm{a}\mathrm{t}\mathrm{e}\mathrm{=}\frac{\mathrm{c}\text{umulative}\mathrm{}\text{deaths}}{\mathrm{c}\text{umulative}\mathrm{}\text{cases}}\mathrm{;}\mathrm{c}\text{ure}\mathrm{}\text{rate}\mathrm{=}\frac{\mathrm{c}\text{umulative}\mathrm{}\text{cured}\mathrm{}\text{cases}}{\mathrm{c}\text{umulatives}\mathrm{}\text{cases}}$; cumulative cases = regular cases + new cases + severe cases + cumulative deaths + cumulative cured.

The above data only represented cases in mainland of China, Hong Kong, Taiwan, and Macau were excluded. Data were collected from National Health Commission of the People's Republic of China. Available from http://www.nhc.gov.cn/xcs/yqtb/list_gzbd.shtml

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.